Cholangiopathy as part of post-COVID syndrome Academic Article


  • Journal of Translational Autoimmunity


  • Liver compromise in critically ill patients with coronavirus disease 2019 (COVID-19) is common but usually transient and self-limited. However, liver tests on some patients continue to show abnormal results. Herein, a 29-year-old patient with clinical and histological features of cholangiopathy is presented. Despite treatment with ursodeoxycholic acid and cholestyramine, bilirubin and transaminase levels remained elevated. This case report raises awareness of the difficulty of managing this condition in patients with COVID-19.

publication date

  • 2021-8-31


  • 4

International Standard Serial Number (ISSN)

  • 2589-9090

number of pages

  • 3

start page

  • 1

end page

  • 3